272 related articles for article (PubMed ID: 29753615)
1. Targeting the proinflammatory cytokines, oxidative stress, apoptosis and TGF-β1/STAT-3 signaling by irbesartan to ameliorate doxorubicin-induced hepatotoxicity.
Kabel AM; Alzahrani AA; Bawazir NM; Khawtani RO; Arab HH
J Infect Chemother; 2018 Aug; 24(8):623-631. PubMed ID: 29753615
[TBL] [Abstract][Full Text] [Related]
2. Zinc/alogliptin combination attenuates testicular toxicity induced by doxorubicin in rats: Role of oxidative stress, apoptosis and TGF-β1/NF-κB signaling.
Kabel AM
Biomed Pharmacother; 2018 Jan; 97():439-449. PubMed ID: 29091894
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic effects of angiotensin II type 1 receptor blocker, irbesartan, on non-alcoholic steatohepatitis using FLS-ob/ob male mice.
Kato J; Koda M; Kishina M; Tokunaga S; Matono T; Sugihara T; Ueki M; Murawaki Y
Int J Mol Med; 2012 Jul; 30(1):107-13. PubMed ID: 22469867
[TBL] [Abstract][Full Text] [Related]
4. Montelukast and irbesartan ameliorate metabolic and hepatic disorders in fructose-induced metabolic syndrome in rats.
Ibrahim MA; Amin EF; Ibrahim SA; Abdelzaher WY; Abdelrahman AM
Eur J Pharmacol; 2014 Feb; 724():204-10. PubMed ID: 24370493
[TBL] [Abstract][Full Text] [Related]
5. Pregnenolone protects the liver against doxorubicin-induced cellular injury by anti-inflammatory, antioxidant, and antiapoptotic mechanisms: role of Keap1/Nrf2/HO-1 and P-glycoprotein.
Morsy MA; El-Daly M; Kamel BA; Rifaai RA; Abdel-Gaber SA
Eur Rev Med Pharmacol Sci; 2023 May; 27(10):4718-4734. PubMed ID: 37259756
[TBL] [Abstract][Full Text] [Related]
6. Irbesartan suppresses cardiac toxicity induced by doxorubicin via regulating the p38-MAPK/NF-κB and TGF-β1 pathways.
El-Said NT; Mohamed EA; Taha RA
Naunyn Schmiedebergs Arch Pharmacol; 2019 Jun; 392(6):647-658. PubMed ID: 30734091
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-128-3p aggravates doxorubicin-induced liver injury by promoting oxidative stress via targeting Sirtuin-1.
Zhao X; Jin Y; Li L; Xu L; Tang Z; Qi Y; Yin L; Peng J
Pharmacol Res; 2019 Aug; 146():104276. PubMed ID: 31112750
[TBL] [Abstract][Full Text] [Related]
8. Ameliorative Effect of Gallic Acid in Doxorubicin-Induced Hepatotoxicity in Wistar Rats Through Antioxidant Defense System.
Omobowale TO; Oyagbemi AA; Ajufo UE; Adejumobi OA; Ola-Davies OE; Adedapo AA; Yakubu MA
J Diet Suppl; 2018 Mar; 15(2):183-196. PubMed ID: 28718673
[TBL] [Abstract][Full Text] [Related]
9. Turmeric Extract-loaded Selenium Nanoparticles Counter Doxorubicin-induced Hepatotoxicity in Mice
ALRashdi BM; Hussein MM; Mohammed RM; Abdelhamed NW; Asaad ME; Alruwaili M; Alrashidi SM; Habotta OA; Abdel Moneim AE; Ramadan SS
Anticancer Agents Med Chem; 2024; 24(6):443-453. PubMed ID: 38204261
[TBL] [Abstract][Full Text] [Related]
10. Targeting proinflammatory cytokines, oxidative stress, TGF-β1 and STAT-3 by rosuvastatin and ubiquinone to ameliorate trastuzumab cardiotoxicity.
Kabel AM; Elkhoely AA
Biomed Pharmacother; 2017 Sep; 93():17-26. PubMed ID: 28622591
[TBL] [Abstract][Full Text] [Related]
11. Targeting oxidative stress, proinflammatory cytokines, apoptosis and toll like receptor 4 by empagliflozin to ameliorate bleomycin-induced lung fibrosis.
Kabel AM; Estfanous RS; Alrobaian MM
Respir Physiol Neurobiol; 2020 Feb; 273():103316. PubMed ID: 31600583
[TBL] [Abstract][Full Text] [Related]
12. Effect of Acacia hydaspica R. Parker extract on lipid peroxidation, antioxidant status, liver function test and histopathology in doxorubicin treated rats.
Afsar T; Razak S; Almajwal A
Lipids Health Dis; 2019 May; 18(1):126. PubMed ID: 31142345
[TBL] [Abstract][Full Text] [Related]
13. Protective Effect of Boswellic Acids against Doxorubicin-Induced Hepatotoxicity: Impact on Nrf2/HO-1 Defense Pathway.
Barakat BM; Ahmed HI; Bahr HI; Elbahaie AM
Oxid Med Cell Longev; 2018; 2018():8296451. PubMed ID: 29541348
[TBL] [Abstract][Full Text] [Related]
14. Yellow Wine Polyphenolic Compounds prevents Doxorubicin-induced cardiotoxicity through activation of the Nrf2 signalling pathway.
Lin H; Zhang J; Ni T; Lin N; Meng L; Gao F; Luo H; Liu X; Chi J; Guo H
J Cell Mol Med; 2019 Sep; 23(9):6034-6047. PubMed ID: 31225944
[TBL] [Abstract][Full Text] [Related]
15. Molecular mechanisms of irbesartan suppressing atherosclerosis in high cholesterol-diet apolipoprotein E knock-out mice.
Yao R; Cheng X; Chen Y; Xie JJ; Yu X; Liao MY; Ding YJ; Tang TT; Liao YH
Int J Cardiol; 2010 Mar; 139(2):113-22. PubMed ID: 19028402
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin II receptor blocker ameliorates stress-induced adipose tissue inflammation and insulin resistance.
Hayashi M; Takeshita K; Uchida Y; Yamamoto K; Kikuchi R; Nakayama T; Nomura E; Cheng XW; Matsushita T; Nakamura S; Murohara T
PLoS One; 2014; 9(12):e116163. PubMed ID: 25551221
[TBL] [Abstract][Full Text] [Related]
17. The effect of natural antioxidants in cyclophosphamide-induced hepatotoxicity: Role of Nrf2/HO-1 pathway.
Sherif IO
Int Immunopharmacol; 2018 Aug; 61():29-36. PubMed ID: 29800788
[TBL] [Abstract][Full Text] [Related]
18. Silymarin modulates doxorubicin-induced oxidative stress, Bcl-xL and p53 expression while preventing apoptotic and necrotic cell death in the liver.
Patel N; Joseph C; Corcoran GB; Ray SD
Toxicol Appl Pharmacol; 2010 Jun; 245(2):143-52. PubMed ID: 20144634
[TBL] [Abstract][Full Text] [Related]
19. The intervention effect of zinc supplementation on irbesartan treatment for atherosclerosis of ApoE-/- mice.
Li S; Wang K; Xu G; Ji J; Qin C
Pak J Pharm Sci; 2016 Nov; 29(6):1907-1912. PubMed ID: 28375105
[TBL] [Abstract][Full Text] [Related]
20. Systemic and local effects of angiotensin II blockade in experimental diabetic nephropathy.
Vieitez P; Gómez O; Uceda ER; Vera ME; Molina-Holgado E
J Renin Angiotensin Aldosterone Syst; 2008 Jun; 9(2):96-102. PubMed ID: 18584585
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
